Cargando…
Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864949/ https://www.ncbi.nlm.nih.gov/pubmed/31744458 http://dx.doi.org/10.1186/s12882-019-1515-7 |
| _version_ | 1783471994234208256 |
|---|---|
| author | Sinha, Shubhadeep D. Bandi, Vamsi Krishna Bheemareddy, Bala Reddy Thakur, Pankaj Chary, Sreenivasa Mehta, Kalpana Pinnamareddy, Vikranth Reddy Pandey, Rajendra Sreepada, Subhramanyam Durugkar, Santosh |
| author_facet | Sinha, Shubhadeep D. Bandi, Vamsi Krishna Bheemareddy, Bala Reddy Thakur, Pankaj Chary, Sreenivasa Mehta, Kalpana Pinnamareddy, Vikranth Reddy Pandey, Rajendra Sreepada, Subhramanyam Durugkar, Santosh |
| author_sort | Sinha, Shubhadeep D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6864949 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68649492019-12-12 Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial Sinha, Shubhadeep D. Bandi, Vamsi Krishna Bheemareddy, Bala Reddy Thakur, Pankaj Chary, Sreenivasa Mehta, Kalpana Pinnamareddy, Vikranth Reddy Pandey, Rajendra Sreepada, Subhramanyam Durugkar, Santosh BMC Nephrol Correction BioMed Central 2019-11-19 /pmc/articles/PMC6864949/ /pubmed/31744458 http://dx.doi.org/10.1186/s12882-019-1515-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Correction Sinha, Shubhadeep D. Bandi, Vamsi Krishna Bheemareddy, Bala Reddy Thakur, Pankaj Chary, Sreenivasa Mehta, Kalpana Pinnamareddy, Vikranth Reddy Pandey, Rajendra Sreepada, Subhramanyam Durugkar, Santosh Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial |
| title | Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial |
| title_full | Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial |
| title_fullStr | Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial |
| title_full_unstemmed | Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial |
| title_short | Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial |
| title_sort | correction to: efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (ckd) undergoing dialysis: a randomized, phase-iii trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864949/ https://www.ncbi.nlm.nih.gov/pubmed/31744458 http://dx.doi.org/10.1186/s12882-019-1515-7 |
| work_keys_str_mv | AT sinhashubhadeepd correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT bandivamsikrishna correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT bheemareddybalareddy correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT thakurpankaj correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT charysreenivasa correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT mehtakalpana correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT pinnamareddyvikranthreddy correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT pandeyrajendra correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT sreepadasubhramanyam correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT durugkarsantosh correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial |